What the New HHS-Wide Nine-Application Cap Means for SBIR/STTR Companies
HHS will limit SBIR/STTR applicants to nine proposals annually, forcing companies to rethink submission volume and funding strategy.
Category: News-worthy Nuggets
On Fridays, any industry news that pertains to our services.
NIH Parent NOFO Update
Certain NIH and FDA components no longer accept clinical trials through Parent NOFOs, creating major application screening risks.
HHS Moving to Clinical Trial Optional
HHS Parent NOFOs now use a clinical trial optional structure, simplifying application selection while changing proposal strategy.
NIH SBIR/STTR Returns With New Parent NOFOs, and a Few Important Signals for Applicants
NIH SBIR/STTR funding is back, but applicants should pay close attention to new structures, requirements, and emerging signals.
Simpler.Grants.gov Just Created a New Way for Applicants to Miss Deadlines
Simpler.Grants.gov may reduce waiting time, but applicants delaying SAM.gov registration could still face devastating submission failures at deadline.
What DOE’s SBIR/STTR Overhaul Signals for Commercialization, Not Just Applications
DOE’s SBIR/STTR overhaul signals a shift toward commercialization outcomes, faster pathways, and tighter alignment between innovation, labs, and market readiness.
SBIR/STTR Has Passed Congress, What Should You Be Doing While It Awaits Signature?
SBIR/STTR has passed Congress and awaits signature. Use this short window to prepare strong proposals before solicitations return.
Why the April 5 NIH SBIR/STTR Deadline Disappeared and What It Signals for Innovators
NIH removed the April 5 SBIR/STTR deadline because no active funding announcements exist. Future opportunities will appear first on Grants.gov.
OLAW is now closed due to the lapse in Federal Government funding
Due to the absence of either a fiscal year 2026 appropriation or a Continuing Resolution for the Department of Health and Human Services, OLAW is now closed.
How to understand the difference between NIH Highlighted Topics and Funding Opportunities
NIH clarifies the difference between Highlighted Topics and Funding Opportunities. Misunderstanding the distinction can undermine proposal success.